Mammography screening for breast cancer-the UK Age trial

Affiliations

¹ Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Women's College Research Institute, Women's College Hospital, Toronto, ON, M5S 1B2, Canada. Electronic address: steven.narod@wchospital.ca.

Comment

Steven A Narod. Lancet Oncol. 2020 Nov.

. 2020 Nov;21(11):e508.

doi: 10.1016/S1470-2045(20)30490-3.

¹ Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Women's College Research Institute, Women's College Hospital, Toronto, ON, M5S 1B2, Canada. Electronic address: steven.narod@wchospital.ca.

No abstract available

Comment in

Mammography screening for breast cancer-the UK Age trial - Authors' reply.
Duffy SW, Sasieni PD. Duffy SW, et al. Lancet Oncol. 2020 Nov;21(11):e510. doi: 10.1016/S1470-2045(20)30627-6. Lancet Oncol. 2020. PMID: 33152302 No abstract available.

Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
Duffy SW, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith RA, Evans A, Blyuss O, Johns L, Ellis IO, Myles J, Sasieni PD, Moss SM. Duffy SW, et al. Lancet Oncol. 2020 Sep;21(9):1165-1172. doi: 10.1016/S1470-2045(20)30398-3. Epub 2020 Aug 12. Lancet Oncol. 2020. PMID: 32800099 Free PMC article. Clinical Trial.